Skip to main content
. 2017 Mar 23;10(3):346–356. doi: 10.1016/j.tranon.2017.01.014

Figure 5.

Figure 5

Tracking ROR expression in individual case studies. (A) ROR1 expression in epithelial/tumor cells in individual cases as indicated by colored dots (blue = normal, red = primary, green = metastatic samples). Y-axis represents ROR expression score, and x-axis represents individual patient. (B) ROR1 expression in stromal cells in individual cases as indicated by colored dots (blue = normal, red = primary, green = metastatic samples). Y-axis represents ROR expression score, and x-axis represents individual patient. (C): ROR2 expression in epithelial/tumor cells in individual cases as indicated by colored dots (blue = normal, red = primary, green = metastatic samples). Y-axis represents ROR expression score, and x-axis represents individual patient. (D) ROR2 expression in stromal cells in individual cases as indicated by indicated by colored dots (blue = normal, red = primary, green = metastatic samples). Y-axis represents ROR expression score, and x-axis represents individual patient. (E) Representative images of ROR1 (left panel) and ROR2 (right panel) in case studies, with noticeable ROR2 expression in stromal components in primary and metastatic samples. (F) Representative image of case ID0681 recurrence showing diffuse and strong ROR2 expression in tumor and stroma.